` Comparison: ACL, CI - Alpha Spread

ACL
vs
CI

Over the past 12 months, ACL has underperformed CI, delivering a return of -18% compared to the CI's +1% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ACL
CI
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

ACL Intrinsic Value
5.53 AUD
Undervaluation 49%
Intrinsic Value
Price
CI Intrinsic Value
673.45 USD
Undervaluation 59%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Australian Clinical Labs Ltd
ASX:ACL
2.82 AUD
Cigna Corp
NYSE:CI
274.7 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ACL, CI

Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Australian Clinical Labs Ltd
Revenue
Cigna Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
ACL, CI

Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Australian Clinical Labs Ltd
ASX:ACL
Cigna Corp
NYSE:CI
FCF is not applicable for financial companies
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ACL
82.7%
CI
LTM 3Y Avg 5Y Avg 10Y Avg
Australian Clinical Labs Ltd
Cigna Corp
Not applicable for financial companies

Operating Margin

ACL
9.2%
CI
LTM 3Y Avg 5Y Avg 10Y Avg
Australian Clinical Labs Ltd
Cigna Corp
Not applicable for financial companies

Net Margin

ACL
4.4%
CI
2.3%

FCF Margin

ACL
23.5%
CI
LTM 3Y Avg 5Y Avg 10Y Avg
Australian Clinical Labs Ltd
Cigna Corp
Not applicable for financial companies

ROE

ACL
18.6%
CI
14.7%

ROA

ACL
5.6%
CI
3.9%

ROIC

ACL
9.1%
CI
LTM 3Y Avg 5Y Avg 10Y Avg
Australian Clinical Labs Ltd
Cigna Corp
Not applicable for financial companies

ROCE

ACL
18.3%
CI
LTM 3Y Avg 5Y Avg 10Y Avg
Australian Clinical Labs Ltd
Cigna Corp
Not applicable for financial companies

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
ACL, CI

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ACL, CI

Loading
ACL
CI
Difference
www.alphaspread.com

Performance By Year
ACL, CI

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ACL to other stocks
Unlock Full Access to Alpha Spread
Create Free Account